4. FiO₂ is stable during use
1 = strongly disagree; 5 = strongly agree
5. Overall clinical performance is as intended use
1 = strongly disagree; 5 = strongly agree
6. Device is easy to setup and operate
1 = strongly disagree; 5 = strongly agree
7. Alarms are clear and useful
1 = strongly disagree; 5 = strongly agree
8. Instructions for Use (IFU) are clear
1 = strongly disagree; 5 = strongly agree
9. Cleaning and maintenance is easy
1 = strongly disagree; 5 = strongly agree
10. Have you observed any unexpected side effects during use?
11. Have you encountered any device malfunctions?
12. Have you observed any misuse?
13. Have you observed off-label use?
14. Do neonates typically show improved oxygenation (SpO₂ 89–96%) within the first 24 hours of Dolphin CPAP therapy?
(Based on your general clinical observations of therapy. Patient data or measured outcomes are not requested.)
15. In your clinical observation, does the patient’s Respiratory Severity Score (RSS) generally improve within the first 24 hours of Dolphin CPAP therapy?
(Based on your general clinical observations of therapy. Patient data or measured outcomes are not requested.)
If available, please record some representative cases below:
